Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant human pentraxin-2

EU orphan designation number: EU/3/12/1020   
Active ingredient: Recombinant human pentraxin-2
Indication: Treatment of idiopathic pulmonary fibrosis
Sponsor: FGK Representative Service GmbH
Heimeranstraße 35, 80339 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/07/2012 Orphan designation EMA/OD/048/12 (2012)5140 of 17/07/2012
17/04/2014 Transfer of orphan designation EMA/OD/048/12/T/01 (2014)2705 of 15/04/2014